COVID-19 vaccines and anaphylaxis-evaluation with skin prick testing, basophil activation test and Immunoglobulin E

Àgnes Csuth¹, Anna Nopp^{2

3}, Jann Storsaeter⁴, Lennart Nilsson¹, Maria C Jenmalm⁵

Affiliations

¹ Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden.
² Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
³ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
⁴ Department of Vaccines, Public Health Agency of Sweden, Solna, Sweden.
⁵ Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

Àgnes Csuth et al. Clin Exp Allergy. 2022 Jun.

. 2022 Jun;52(6):812-819.

doi: 10.1111/cea.14143. Epub 2022 Apr 28.

Àgnes Csuth¹, Anna Nopp^{2

3}, Jann Storsaeter⁴, Lennart Nilsson¹, Maria C Jenmalm⁵

¹ Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping, Sweden.
² Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
³ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
⁴ Department of Vaccines, Public Health Agency of Sweden, Solna, Sweden.
⁵ Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.

No abstract available

Keywords: COVID-19; anaphylaxis; basophil activation test; polyethylene glycol; skin prick test; vaccine.

Conflict of interest statement

No conflict of interest to declare.

1. Castells MC, Phillips EJ. Maintaining safety with SARS‐CoV‐2 vaccines. N Engl J Med. 2021;384:643‐649. doi:10.1056/NEJMra2035343 - DOI - PMC - PubMed
1. Turner PJ, Ansotegui IJ, Campbell DE, et al. Covid‐19 vaccine‐associated anaphylaxis: a statement of the World Allergy Organization Anaphylaxis Committee. World Allergy Organ J. 2021;14:100517. doi:10.1016/j.waojou.2021.100517 - DOI - PMC - PubMed
1. Nilsson L, Csuth Á, Storsaeter J, Garvey LH, Jenmalm MC. Vaccine allergy: evidence to consider for COVID‐19 vaccines. Curr Opin Allergy Clin Immunol. 2021;21(4):401‐409. doi:10.1097/ACI.0000000000000762 - DOI - PMC - PubMed
1. Rasmussen TH, Mortz CG, Georgsen TK, Rasmussen HM, Kjaer HF, Bindslev‐Jensen C. Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up. Clin Transl Allergy. 2021;11:e12044. doi:10.1002/clt2.12044 - DOI - PMC - PubMed
1. Krantz MS, Bruusgaard‐Mouritsen MA, Koo G, Phillips EJ, Stone CA Jr, Garvey LH. Anaphylaxis to the first dose of mRNA SARS‐CoV‐2 vaccines: don’t give up on the second dose! Allergy. 2021;76:2916‐2920. doi:10.1111/all.14958 - DOI - PMC - PubMed